NDC 43742-2123 – Vir Combination

Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen 12 [hp_C]/mL; Human Herpesvirus 5 18 [hp_X]/mL; Human Herpesvirus 1 12 [hp_X]/mL; Human Herpesvirus 2 12… · Liquid · Oral

Human Otc Drug

Product NDC43742-2123

Product details

Brand name
Vir Combination
Generic name
Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum (2022-2023)
Labeler
Deseret Biologicals, Inc.
Dosage form
Liquid
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
January 25, 2024
Marketing end
March 20, 2029
Pharmacologic class
Live Human Adenovirus Type 4 Vaccine

Active ingredients

Uses, dosage, side effects and warnings for VIR Combination →

Package NDC codes (1)

Package NDCDescriptionSince
43742-2123-130 mL in 1 BOTTLE, DROPPER (43742-2123-1)Jan 25, 2024

Other VIR Combination products